Literature DB >> 17588748

Discovery of a novel class of benzazepinone Na(v)1.7 blockers: potential treatments for neuropathic pain.

Scott B Hoyt1, Clare London, David Gorin, Matthew J Wyvratt, Michael H Fisher, Catherine Abbadie, John P Felix, Maria L Garcia, Xiaohua Li, Kathryn A Lyons, Erin McGowan, D Euan MacIntyre, William J Martin, Birgit T Priest, Amy Ritter, McHardy M Smith, Vivien A Warren, Brande S Williams, Gregory J Kaczorowski, William H Parsons.   

Abstract

A series of benzodiazepines and benzazepinones were synthesized and evaluated as potential sodium channel blockers in a functional, membrane potential-based assay. One member of the benzazepinone series, compound 47, displayed potent, state-dependent block of hNa(v)1.7, and was orally efficacious in a rat model of neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17588748     DOI: 10.1016/j.bmcl.2007.05.076

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  17 in total

Review 1.  Na(+) channel blockers for the treatment of pain: context is everything, almost.

Authors:  Michael S Gold
Journal:  Exp Neurol       Date:  2007-12-08       Impact factor: 5.330

Review 2.  AMPK: An emerging target for modification of injury-induced pain plasticity.

Authors:  Theodore J Price; Gregory Dussor
Journal:  Neurosci Lett       Date:  2013-07-03       Impact factor: 3.046

3.  SnAP reagents for the one-step synthesis of medium-ring saturated N-heterocycles from aldehydes.

Authors:  Cam-Van T Vo; Michael U Luescher; Jeffrey W Bode
Journal:  Nat Chem       Date:  2014-03-02       Impact factor: 24.427

Review 4.  Sodium channel blockers for the treatment of neuropathic pain.

Authors:  Anindya Bhattacharya; Alan D Wickenden; Sandra R Chaplan
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

Review 5.  Contribution of primary afferent channels to neuropathic pain.

Authors:  Andrea M Harriott; Michael S Gold
Journal:  Curr Pain Headache Rep       Date:  2009-06

6.  Recent Developments in Neuropathic Pain Mechanisms: Implications for Treatment.

Authors:  Wahida Rahman; Anthony H Dickenson
Journal:  Rev Pain       Date:  2011-06

7.  Green novel multicomponent synthesis and biological evaluation of new oxazolopyrazoloazepines and reduction of nitrophenols in the presence of Ag/Fe3O4/ZnO@MWCNT MNCs.

Authors:  Mehdi Savari; Ali Varasteh-Moradi; S Zahra Sayyed-Alangi; Zinatossadat Hossaini; Ramin Zafar Mehrabian
Journal:  Mol Divers       Date:  2022-03-24       Impact factor: 2.943

Review 8.  Neurological perspectives on voltage-gated sodium channels.

Authors:  Niels Eijkelkamp; John E Linley; Mark D Baker; Michael S Minett; Roman Cregg; Robert Werdehausen; François Rugiero; John N Wood
Journal:  Brain       Date:  2012-09       Impact factor: 13.501

9.  Targeting adenosine monophosphate-activated protein kinase (AMPK) in preclinical models reveals a potential mechanism for the treatment of neuropathic pain.

Authors:  Ohannes K Melemedjian; Marina N Asiedu; Dipti V Tillu; Raul Sanoja; Jin Yan; Arianna Lark; Arkady Khoutorsky; Jessica Johnson; Katherine A Peebles; Talya Lepow; Nahum Sonenberg; Gregory Dussor; Theodore J Price
Journal:  Mol Pain       Date:  2011-09-21       Impact factor: 3.395

10.  Production of benzazepine derivatives via four-component reaction of isatins: study of antioxidant activity.

Authors:  Fathali Gholami Orimi; Behrooz Mirza; Zinatossadat Hossaini
Journal:  Mol Divers       Date:  2020-06-10       Impact factor: 2.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.